[Cryptococcosis in Burundi in 1985. Report of 30 cases] NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Cryptococcosis in Burundi in 1985. Report of 30 cases]

Med Trop (Mars). 1986 Jul-Sep;46(3):249-56. Unique Identifier : AIDSLINE MED/87038689
Laroche R; Hategekimana T; Ndabaneze E; Kadende P; Petat E; Aubry P

Abstract: Over a period of 23 months, 30 cases of cryptococcosis have been studied in Bujumbura (Burundi). Through them, epidemiological and clinical aspects have been underlined, and attempts have been made to establish links between cryptococcosis and A.I.D.S., which is significantly frequent in Central Africa. Cryptococcosis strikes young adults (40% between 30 and 35 years of age). Its high frequency in Bujumbura among patients infested by A.I.D.S., suggest some thoughts. A.I.D.S. in Central Africa, and particularly in Burundi, presents some peculiarities linked to surrounding and possibilities of diagnosis: opportunistic diseases are of different frequency in temperate or tropical climates: pneumocystosis are more frequent in U.S.A. but cryptococcosis and candidosis are more frequent in Africa because their diagnosis is easier. lack of classical risk factors in African populations is known, but other risk factors have to be taken into consideration: tuberculosis, intestinal parasitosis, chronic virus B hepatitis, protein-caloric deficiency.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS Adult Amphotericin B/THERAPEUTIC USE Burundi *Cryptococcosis/DIAGNOSIS/EPIDEMIOLOGY/THERAPY English Abstract Female Human Ketoconazole/THERAPEUTIC USE Male Meningoencephalitis/ETIOLOGY Middle Age JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/complicationsadultamphotericinb/therapeuticuseburundiKWDcryptococcosis/diagnosis/epidemiology/therapyenglishabstractfemalehumanketoconazole/therapeuticusemalemeningoencephalitis/etiologymiddleagejournalarticle
870228
M8720217

Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .